Harrow Health Inc (HROW)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark L. Baum
Employees:
180
102 WOODMONT BLVD, SUITE 610, NASHVILLE, TN, 37215
615.733.4731
-
Formally known as:
- IMPRIMIS PHARMACEUTICALS, INC. NEW
- TRANSDEL PHARMACEUTICALS, INC.
| Date | Ratio |
|---|---|
| 2007-09-21 | 0.4625:1 |
| 2012-02-24 | 1:8 |
| 2013-02-08 | 1:5 |
Harrow Health, Inc. owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|